Stay updated on NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-02T15:45:57.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    An NIH-wide banner announces updates to terminology for artificial intelligence across NIH content.
    Difference
    0.3%
    Check dated 2026-10-26T14:29:36.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2, reflecting a website release update.
    Difference
    0.0%
    Check dated 2026-10-19T14:16:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-12T15:16:37.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The revision shown in the history updates from v3.6.6 to v3.7.0, signaling a newer version of the study record has been published. This reflects an update to the page's revision metadata rather than changes to the trial data.
    Difference
    0.0%
    Check dated 2026-09-21T20:35:21.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added, replacing Revision: v3.6.5. This indicates a small software update to the page’s version information.
    Difference
    0.0%
    Check dated 2026-08-31T16:31:49.000Z thumbnail image

Stay in the know with updates to NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.